Home / Online GXP courses / Cross-Industry / EU AI Act for Pharmaceuticals and Medical Devices
Successful completion provides learners with a dated, traceable and downloadable certificate for the course :
Each certificate is CPD/CEU accredited and 21 CFR PART 11 compliant. Certificates validity can be checked online through our certificate online checker. They can also be shared on Linkedin.
When an AI model misreads a scan or a sepsis alert fires too late, the harm can reach patients at scale, and regulators now hold the organization accountable. Regulation (EU) 2024/1689, the EU AI Act, is the world’s first comprehensive AI law, and it governs artificial intelligence across drug discovery, clinical trials, pharmacovigilance, manufacturing and diagnostics. It sorts every system by risk, sets a full set of duties for the high-risk tier where most life sciences AI lands, and works alongside the MDR, the IVDR, GxP and the GDPR. From August 2026, those obligations apply across the European Union, and compliance is mandatory. Non-compliance can bring fines up to €35 million or 7% of global turnover, refused CE marking and product withdrawal. This two-hour online training turns every article into one clear method to apply, from first risk classification to post-market monitoring.
Across ten lessons, this certified course covers every part of the Act with real case studies, from scope and the risk-based pyramid to conformity assessment, general-purpose AI and enforcement. Its traceable certificate gives you audit-ready proof that you, or your team, are ready to apply the EU AI Act in practice.
What you’ll learn
Who should enroll
Upon successful completion, each learner receives a validated certificate accredited with CPD/CEU credits, suitable for audit and compliance documentation.
Lesson: A Brief History of AI Regulation in Life Sciences
Lesson 1: Foundations of the EU AI Act
Lesson 2: The Risk-Based Pyramid and Prohibited Practices
Lesson 3: Is Your System High-Risk? The Classification Rules
Lesson 4: The Seven Requirements for High-Risk AI
Lesson 5: Roles and Responsibilities Across the AI Value Chain
Lesson 6: AI as a Medical Device, Where the AI Act Meets the MDR and IVDR
Lesson 7: AI in Drug Development, Clinical Trials and Pharmacovigilance
Lesson 8: Conformity Assessment, CE Marking and the Fundamental Rights Impact Assessment
Lesson 9: General-Purpose AI and Foundation Models in Life Sciences
Lesson 10: Governance, Enforcement and Building Your Compliance Program
Conclusion
Glossary
Final Assessment
Large group ? Request a quote !
$95.00 / year
$95.00 / year